DecisionDx-SCC
Cutaneous Squamous Cell Carcinoma
Commercial/Ongoing ValidationActive
Key Facts
Indication
Cutaneous Squamous Cell Carcinoma
Phase
Commercial/Ongoing Validation
Status
Active
Company
About Castle Biosciences
Castle Biosciences is a mission-driven company focused on transforming disease management by applying precision genomics to high-stakes clinical decisions. Since its 2008 founding, it has built a commercially successful portfolio of proprietary tests, supported by over 150 peer-reviewed publications and more than 300,000 test reports delivered. Its strategy centers on addressing critical unmet needs in dermatologic, ocular, and gastrointestinal oncology through its multi-analyte GEP platform, driving growth via clinical validation, payer coverage, and market penetration.
View full company profile